Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients

doi:10.5306/wjco.v15.i8.1033

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (744)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-7) series.

Item

Count

PDF

HTML

456

Figures (1-3)

Tables (1-7)

Sum=597

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=129

Aug 24, 2024 (publication date) through Oct 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Aug 24, 2024; 15(8): 1033-1047
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1033

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow chart of patients included in the study.

Open in New Tab Full Size Figure Download Figure

Figure 2 Overall survival. A: Overall survival (OS) according to different tumor markers in all patients; B: OS according to different scores in all patients; C: OS between high score patients and low score patients. AFP: Alpha foetoprotein; CEA: Carcinoembryonic antigen.

Open in New Tab Full Size Figure Download Figure

Figure 3 Overall survival according to different scores in different stages patients. A: Overall survival of patients with stage I; B: Overall survival of patients with stage II; C: Overall survival of patients with stage III.

Citation: Sun AH, Zhang XY, Huang YY, Chen L, Wang Q, Jiang XC. Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients. World J Clin Oncol 2024; 15(8): 1033-1047
URL: https://www.wjgnet.com/2218-4333/full/v15/i8/1033.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i8.1033